Cad Cure Tablet contains nutritional supplements used to treat neuropathic pain associated with diabetic neuropathy and nutritional deficiencies. Cad Cure Tablet might help enhance blood calcium levels, fasten metabolism, facilitate the conversion of glucose into energy, helps improve the body’s oxidative stores, and develop healthy red blood cells. Diabetic neuropathy is a condition in which nerve damage occurs due to high blood glucose levels. It mostly damages the nerves in the legs and feet. A nutritional deficiency occurs when the body does not absorb or get enough nutrients from food.
Cad Cure Tablet consists of five supplements: Alpha-lipoic acid, Methylcobalamin, Vitamin D3, Folic acid, and Pyridoxine. Methylcobalamin and pyridoxine help rejuvenate and protect damaged nerve cells by producing a substance called myelin. Alpha-lipoic acid is an antioxidant that prevents oxidative stress, thereby helping to provide a protective effect on the nerve tissues and brain. Vitamin D3 helps in resolving neuropathic symptoms and improves balance. Folic acid helps in providing essential nutrients. Together, Cad Cure Tablet helps treat diabetic neuropathy and nutritional deficiencies.
You are advised to take Cad Cure Tablet for as long as your doctor has recommended it for you, depending on your medical condition. In some cases, you may experience certain common side effects, such as stomach upset, diarrhoea, nausea, and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
Consult your doctor before taking Cad Cure Tablet if you are pregnant or breastfeeding. Limited information is available regarding the usage of Cad Cure Tablet in children, so please consult a doctor. Drive only if you are alert as it is unknown if Cad Cure Tablet affects your ability to drive. Keep your doctor informed about your health condition and medicines to rule out any side effects/interactions.